Tanaka Y, Hongo K, Tada T, Takizawa T, Kakizawa Y, Koyama J, Kobayashi S, Sakurai A, Hashizume K
Department of Neurosurgery, Shinshu University, School of Medicine, Asahi 3-1-1, Matsumoto 390-8621, Japan.
No Shinkei Geka. 2000 Dec;28(12):1087-92.
We analyzed 7 pituitary adenomas in patients with multiple endocrine neoplasia type 1 (MEN1). Their incidence was 1.6% among 450 patients with pituitary adenomas which had been treated surgically in our department between 1978 and 1999. The age, gender, symptoms, type of hormone secretion, pathological and operative findings in the MEN1 patients were not apparently different from those in the non-MEN1 patients. Incidence of non-functioning pituitary adenomas, however, was more frequently encountered in our series than that in previous reports among Caucasian people. One patient who had 5 previous operations for the MEN tumors died following postoperative subarachnoid hemorrhage. Four of the seven patients presented initial symptoms related to pituitary adenomas and increased serum Ca level was retrospectively recognized in three of the four at the time of treatment for the pituitary adenomas.
我们分析了7例1型多发性内分泌腺瘤病(MEN1)患者的垂体腺瘤。在1978年至1999年间于我院接受手术治疗的450例垂体腺瘤患者中,其发生率为1.6%。MEN1患者的年龄、性别、症状、激素分泌类型、病理及手术结果与非MEN1患者相比无明显差异。然而,在我们的系列研究中,无功能垂体腺瘤的发生率比以往白种人相关报道更为常见。1例曾因MEN肿瘤接受过5次手术的患者术后发生蛛网膜下腔出血死亡。7例患者中有4例最初表现出与垂体腺瘤相关的症状,在对垂体腺瘤进行治疗时,4例中的3例经回顾性分析发现血清钙水平升高。